Leveraging nanoparticles' potential in the development of mRNA vaccines

In the new year, mRNA vaccines have proven to be a groundbreaking vaccination option. Unlike traditional vaccinations that use live or deactivated viruses to induce a resistant response, mRNA vaccines use a portion of the virus’s genetic material. But what makes these vaccines so active, and how do they just work? The thinkable uses of nanoparticles are one module of the solution. Particles as small as one to one hundred nanometers are called nanoparticles. They can be made from numerous …